Innovagram Swiss

Innovagram Swiss is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about Innovagram Swiss. Innovagram is a Swiss company with subsidiaries in Italy growing selected crops to extract active compounds for pharma, nutritional and cosmetic uses. Thanks to extensive R&D the company is able to obtain several active compounds such as CBD, CBN, CBG. Innovagram is a Swiss company running an integrated business in the cannabis sector that includes growing, harvesting, processing, extraction of isolates, manufacturing of cosmetic, pharmaceutical and food products. Innovagram Gmbh, the parent company with headquarters in Lugano, Switzerland with a fully owned subsidiary in Italy, has entered into an agreement with Salute Sativa, a fully licensed Italian cooperative with the largest Italian hemp agricultural network, with an existing cultivated area of 1000ha. Innovagram will purchase assets and contracts from Salute Sativa. Through an investment into its own advanced extraction plant, Innovagram will be able to obtain GMP pharma certification and to produce active compounds to be used in the pharma and cosmetics business. Extensive R&D and patented processes already enable Innovagram to extract new cannabinoids on top of CBD, such as CBDa, CBN, CBG, CBC, which are currently in high demand for pharma and nutraceutical use and produced by just a few companies worldwide. KEY POINTS ● Innovagram is vertically integrated and diversified, with its own R&D working on new, highly profitable isolates. ● Net profit in 2020 from sales of CBD and CBN projected as €17M, EBITDA above 70%. ● Over 20 new products are already registered and ready to be sold. ● Management team with in-depth market knowledge and experience. The management team of Innovagram will leverage upon its in-depth market knowledge with considerable expertise in cannabis market, trading and risk management to develop existing and create new opportunities, to overcome the competitive and logistical barriers.